Nuts and Bolts of Subcutaneous Therapy.

Clinical Decision-Making Disease Management Disease Susceptibility Drug Monitoring Humans Immunization, Passive / adverse effects Immunoglobulins / administration & dosage Immunoglobulins, Intravenous Infusions, Subcutaneous Injections, Subcutaneous Primary Immunodeficiency Diseases / diagnosis Treatment Outcome
Immune deficiency Immunoglobulin replacement therapy SCIG Subcutaneous infusion

Journal

Immunology and allergy clinics of North America
ISSN: 1557-8607
Titre abrégé: Immunol Allergy Clin North Am
Pays: United States
ID NLM: 8805635

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 14 7 2020
pubmed: 14 7 2020
medline: 16 6 2021
Statut: ppublish

Résumé

Immunoglobulin replacement therapy is standard of care in treatment of many primary immunodeficiency diseases. The goal of replacement therapy is to reduce infections in individuals with primary immune deficiency and improve their quality of life. Immunoglobulin replacement therapy is most often lifelong, therefore ease of administration is vital for adherence to treatment. Self-infusion via subcutaneous intravenous immunoglobulin (SCIG) allows patient input to design an individualized and optimal treatment plan. Because SCIG regimens are flexible and allow for increased autonomy, patients receiving SCIG report improved quality of life. This article summarizes the dosing, administration, and adverse event management of SCIG infusions.

Identifiants

DOI: 10.1016/j.iac.2020.04.002 PMID: 32654697
pubmed: 32654697
pii: S0889-8561(20)30022-9
doi: 10.1016/j.iac.2020.04.002
pii:
doi:

Substances chimiques

Immunoglobulins 0
Immunoglobulins, Intravenous 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

527-537

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure C. Duff: CSL Behring, nurse consultant; Takeda, presenter; Grifols, nurse consultant. M. Ballow: physician advisory board and speaker bureau for CSL Behring, Takeda, and Grifols; consulting medical director for the Immune Deficiency Foundation; Data Safety Monitoring Board, Prometic, Glenmark.

Auteurs

Carla Duff (C)

Department of Allergy and Immunology, College of Medicine, College of Nursing, University of South Florida, 601 5th Street South, St Petersburg, FL 33701, USA.

Mark Ballow (M)

Division of Allergy and Immunology, Department of Pediatrics, Children's Research Institute, University of South Florida, Johns Hopkins All Children's Hospital, 140 7th Avenue South, CRI 4008, St Petersburg, FL 33701, USA. Electronic address: mballow@usf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Diagnostic › Prise de décision clinique › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Prise en charge de la maladie › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Prédisposition aux maladies › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Monitorage physiologique › Surveillance des médicaments › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Immunisation passive › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Immunoglobulines par voie veineuse › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Voies d'administration de substances chimiques et des médicaments › Perfusions parentérales › Perfusions sous-cutanées › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Voies d'administration de substances chimiques et des médicaments › Injections › Injections sous-cutanées › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Maladies d'immunodéficience primaire › Nuts and Bolts of Subcutaneous Therapy.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Nuts and Bolts of Subcutaneous Therapy.